Your browser is no longer supported. Please, upgrade your browser.
ARYA Sciences Acquisition Corp IV
Index- P/E- EPS (ttm)- Insider Own3.20% Shs Outstand18.87M Perf Week0.20%
Market Cap202.99M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float14.95M Perf Month-5.62%
Income- PEG- EPS next Q- Inst Own93.80% Short Float0.04% Perf Quarter-7.71%
Sales- P/S- EPS this Y- Inst Trans0.89% Short Ratio0.46 Perf Half Y-
Book/sh7.71 P/B1.32 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh0.04 P/C253.74 EPS next 5Y- ROE- 52W Range10.05 - 12.38 Perf YTD-8.63%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-17.85% Beta-
Dividend %- Quick Ratio9.10 Sales past 5Y- Gross Margin- 52W Low1.19% ATR0.22
Employees- Current Ratio9.10 Sales Q/Q- Oper. Margin- RSI (14)42.57 Volatility0.40% 1.79%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.04 Prev Close10.15
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume12.00K Price10.17
Recom- SMA20-2.25% SMA50-2.56% SMA200-4.43% Volume423 Change0.20%
ARYA Sciences Acquisition Corp IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.